Inactive Instrument
BiVictriX Therapeutics plc Share Price
Stocks
BVX
GB00BNXH3K91
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +17.65% |
| Manager | Title | Age | Since |
|---|---|---|---|
Tiffany Thorn
CEO | Chief Executive Officer | 39 | 31/12/2015 |
Adrian Howd
DFI | Director of Finance/CFO | 54 | 02/10/2023 |
Alison Halsall
SEC | Corporate Secretary | - | 12/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Tiffany Thorn
BRD | Director/Board Member | 39 | 31/12/2015 |
Susan Lowther
BRD | Director/Board Member | 67 | 21/09/2021 |
William Paris
BRD | Director/Board Member | 75 | 21/09/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/09/24 | Buy | Director | 20,000 | 0.0242% | ||
| 02/09/24 | Sell | Director | 20,000 | 0.0242% | ||
| 13/08/24 | Free | Executive/Senior Manager | 320,000 | 0.3878% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +17.65% | +33.33% | - | - | 10.49M | |
| -0.71% | -6.35% | -2.99% | +9.37% | 45.48B | |
| +0.21% | -2.98% | +337.74% | +520.30% | 43.68B | |
| +1.74% | -2.24% | +39.82% | +20.85% | 43.09B | |
| +1.38% | -3.28% | +6.84% | +73.19% | 39.4B | |
| -1.44% | -5.26% | +8.97% | +39.76% | 31.91B | |
| +0.87% | -2.60% | - | - | 17.31B | |
| +0.75% | -0.64% | +19.75% | +108.58% | 16.4B | |
| -0.31% | -2.78% | +10.78% | +30.20% | 14.24B | |
| +1.93% | -3.55% | +82.00% | +36.66% | 13.28B | |
| Average | +2.21% | -3.20% | +62.86% | +104.87% | 29.42B | |
| Weighted average by Cap. | +0.41% | -3.50% | +74.57% | +124.86% |
Employees
-
